Scientific discovery
Identifying biologically active microbial components and exploring their interactions with host systems.
SCIENCE-LED MICROBIOME INNOVATION
The next frontier in microbiome innovation goes beyond which microbes are present. It asks how microbial components interact with the body. At veMico, we turn that question into defined postbiotic ingredient technology. Drawing on decades of microbiome expertise, targeted biological research and human clinical investigation, we develop defined ingredients for brands building the next generation of nutrition products.
Distinctive science. Defined ingredients. New formulation opportunities.
We help nutrition brands explore proprietary postbiotic technology supported by preparation-specific research, technical documentation and formulation expertise.

Identifying biologically active microbial components and exploring their interactions with host systems.
Turning research into characterised, reproducible postbiotic preparations through targeted development and controlled processing.
Evaluating specific ingredient outcomes in controlled human studies, alongside analytical and mechanistic research.
OUR FLAGSHIP INGREDIENT TECHNOLOGY
VMK223 is veMico’s proprietary, non-viable postbiotic derived from Bifidobacterium breve BB091109. Its characterised composition includes microbial exopolysaccharide and cell-wall components. Investigated in laboratory models and in two published standalone randomised, placebo-controlled human trials, it brings together an identifiable preparation, published evidence and experience in finished nutritional products.
Explore VMK223 →Explore human evidence →
Defined postbiotic preparation
Host-centred microbiome research
Human clinical evidence
Practical formulation characteristics
THE SCIENCE
Microbiome science is often discussed in terms of changing microbial populations. veMico also investigates the interface between microbial components and host biology, including receptor-associated signalling and epithelial barrier-related pathways. Laboratory mechanisms are investigated separately from outcomes measured in people.
Explore Science & Technology →
APPLICATION OPPORTUNITIES
VMK223's characterised biological activities and human research programme provide a scientific foundation for exploring applications across multiple areas of health and wellbeing.

Supporting innovation in women's midlife nutrition, informed by human research investigating inflammatory and endocrine markers.
Learn More →
Developing evidence-led skin health formulations, supported by published human research demonstrating improvements in skin hydration, elasticity and wrinkle appearance.
Learn More →
Exploring gut health applications through our understanding of microbiota–host interactions, epithelial barrier biology and consumer experience with VMK223-containing formulations.
Learn More →
Investigating applications in metabolic health and healthy ageing, informed by mechanistic research and early human findings from combination formulations.
Learn More →FORMULATION SUPPORT
We work with nutrition brands, ingredient partners and manufacturers to assess VMK223 in differentiated products, including scientific documentation, intended dose, processing, compatibility and supply requirements.
Our Formulation Support →
Technical information and guidance
Application concepts and dose ranging
Stability and compatibility insights
FROM RESEARCH TO REAL-WORLD APPLICATIONS
The Y Collection includes VMK223-containing Y SKIN capsules and Y GUT sensitive powder. These demonstrate finished-product formulation experience.
Explore Consumer Experience →
LET'S BRING MICROBIOME INNOVATION TO MARKET
Discuss your product concept with our scientific and commercial team. We can provide the evidence, technical information and formulation guidance needed for an informed evaluation.